DMKJ
MREO

David M. Knott Jr’s Mereo BioPharma MREO Stock Holding History

David M. Knott Jr’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-300,337
Closed -$99.1K – 93
2026
Q1 		$99.1K Hold
300,337
– – 0.06% 65
2025
Q4 		$125K Hold
300,337
– – 0.06% 64
2025
Q3 		$619K Sell
300,337
-19,000
-6% -$35K 0.25% 47
2025
Q2 		$865K Hold
319,337
– – 0.39% 35
2025
Q1 		$719K Sell
319,337
-11,663
-4% -$33K 0.34% 36
2024
Q4 		$1.16M Hold
331,000
– – 0.42% 28
2024
Q3 		$1.36M Buy
331,000
+95,000
+40% +$393K 0.48% 32
2024
Q2 		$850K Buy
236,000
+206,000
+687% +$667K 0.34% 39
2024
Q1 		$99K Buy
+30,000
New +$102K 0.04% 72

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

David M. Knott Jr's MREO Position: Q2 2026 in Review

David M. Knott Jr sold out of Mereo BioPharma (MREO) in Q2 2026, closing a stake of 300,337 shares — an estimated $99.1K sold.

David M. Knott Jr first reported a position in MREO in Q1 2024 and held it in 9 quarters. The position peaked at $1.36M in Q3 2024. 61 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • David M. Knott Jr reported no remaining Mereo BioPharma position as of Q2 2026 after selling out during the quarter.
  • David M. Knott Jr sold 300,337 Mereo BioPharma shares in Q2 2026, an estimated $99.1K.
  • David M. Knott Jr first reported a position in Mereo BioPharma in Q1 2024 and held it in 9 quarters.
  • David M. Knott Jr's Mereo BioPharma position peaked at $1.36M in Q3 2024.
  • 61 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.